ExploreWatchlistsPricing
  1. JP-listed companies
  2. J Frontier Co.,Ltd.
  3. Financials
  4. Revenue growth (%)

J Frontier Co.,Ltd. (2934)

Market cap
¥8.8B
P/E ratio
85.4x
J-Frontier develops and sells health supplements and pharmaceuticals while operating SOKUYAKU, a medical platform for online consultations and prescription delivery.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
May 31, 202521.4+313.73%
May 31, 20245.2-87.64%
May 31, 202341.8+4.99%
May 31, 202239.8+104.10%
May 31, 202119.5+22.00%
May 31, 202016-10.41%
May 31, 201917.9-40.37%
May 31, 201830-69.29%
May 31, 201797.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat